Abpro (ABP) Competitors $0.22 -0.01 (-4.28%) As of 12:03 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABP vs. NRXP, CELU, ALXO, ALGS, IMMX, CUE, GNTA, PDSB, DTIL, and KPTIShould you be buying Abpro stock or one of its competitors? The main competitors of Abpro include NRx Pharmaceuticals (NRXP), Celularity (CELU), ALX Oncology (ALXO), Aligos Therapeutics (ALGS), Immix Biopharma (IMMX), Cue Biopharma (CUE), Genenta Science (GNTA), PDS Biotechnology (PDSB), Precision BioSciences (DTIL), and Karyopharm Therapeutics (KPTI). These companies are all part of the "pharmaceutical products" industry. Abpro vs. Its Competitors NRx Pharmaceuticals Celularity ALX Oncology Aligos Therapeutics Immix Biopharma Cue Biopharma Genenta Science PDS Biotechnology Precision BioSciences Karyopharm Therapeutics Abpro (NASDAQ:ABP) and NRx Pharmaceuticals (NASDAQ:NRXP) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends. Do analysts rate ABP or NRXP? Abpro currently has a consensus target price of $4.00, suggesting a potential upside of 1,743.32%. NRx Pharmaceuticals has a consensus target price of $34.50, suggesting a potential upside of 1,065.54%. Given Abpro's higher probable upside, research analysts clearly believe Abpro is more favorable than NRx Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abpro 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NRx Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility and risk, ABP or NRXP? Abpro has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500. Comparatively, NRx Pharmaceuticals has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. Do insiders and institutionals hold more shares of ABP or NRXP? 23.3% of Abpro shares are owned by institutional investors. Comparatively, 4.3% of NRx Pharmaceuticals shares are owned by institutional investors. 13.7% of Abpro shares are owned by insiders. Comparatively, 19.0% of NRx Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to ABP or NRXP? In the previous week, NRx Pharmaceuticals had 8 more articles in the media than Abpro. MarketBeat recorded 10 mentions for NRx Pharmaceuticals and 2 mentions for Abpro. Abpro's average media sentiment score of 1.33 beat NRx Pharmaceuticals' score of 0.98 indicating that Abpro is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abpro 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NRx Pharmaceuticals 4 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ABP or NRXP more profitable? Company Net Margins Return on Equity Return on Assets AbproN/A N/A -241.16% NRx Pharmaceuticals N/A N/A -550.94% Which has preferable earnings & valuation, ABP or NRXP? Abpro has higher revenue and earnings than NRx Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbpro$180K96.65-$7.23MN/AN/ANRx PharmaceuticalsN/AN/A-$25.13M-$2.24-1.32 SummaryAbpro beats NRx Pharmaceuticals on 6 of the 11 factors compared between the two stocks. Get Abpro News Delivered to You Automatically Sign up to receive the latest news and ratings for ABP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABP vs. The Competition Export to ExcelMetricAbproMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.40M$3.07B$5.65B$10.32BDividend YieldN/A2.36%5.68%4.61%P/E RatioN/A20.6175.6626.31Price / Sales96.65400.28521.00169.30Price / CashN/A45.9137.5661.52Price / Book-0.759.7012.996.34Net Income-$7.23M-$52.73M$3.29B$270.94M7 Day Performance8.50%1.20%-0.03%0.29%1 Month Performance-11.46%6.93%4.13%6.89%1 Year PerformanceN/A19.33%69.08%29.31% Abpro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABPAbpro3.4638 of 5 stars$0.22-4.3%$4.00+1,743.3%N/A$17.40M$180K0.0015NRXPNRx Pharmaceuticals3.3037 of 5 stars$3.07+2.9%$34.50+1,025.6%+85.7%$59.05MN/A-1.332Trending NewsAnalyst ForecastCELUCelularity1.3446 of 5 stars$2.16+0.3%$6.00+178.3%-29.1%$58.16M$54.22M-0.69220Positive NewsALXOALX Oncology3.6906 of 5 stars$1.09+0.5%$3.30+204.1%-20.5%$58.10MN/A-0.4940Positive NewsALGSAligos Therapeutics3.3897 of 5 stars$9.31+4.0%$50.00+437.3%+31.9%$57.29M$3.94M-0.4790Positive NewsGap DownIMMXImmix Biopharma3.1038 of 5 stars$1.98-1.0%$8.00+304.0%+25.0%$57.08MN/A-2.579CUECue Biopharma1.5698 of 5 stars$0.74-1.1%N/A+46.0%$56.49M$9.29M-1.3160GNTAGenenta Science2.8569 of 5 stars$3.08+2.2%$25.00+713.0%-21.3%$56.24MN/A0.007Gap UpPDSBPDS Biotechnology2.0717 of 5 stars$1.18-1.7%$10.00+747.5%-66.1%$55.97MN/A-1.2920News CoveragePositive NewsDTILPrecision BioSciences3.8948 of 5 stars$4.66-0.2%$47.00+908.6%-44.2%$54.88M$68.70M-0.53200KPTIKaryopharm Therapeutics3.7232 of 5 stars$6.25-0.2%$34.00+444.4%-34.8%$54.14M$145.24M-0.43380 Related Companies and Tools Related Companies NRXP Alternatives CELU Alternatives ALXO Alternatives ALGS Alternatives IMMX Alternatives CUE Alternatives GNTA Alternatives PDSB Alternatives DTIL Alternatives KPTI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABP) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abpro Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abpro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABP Stock Alerts